Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
eli lilly
12
×
biotech
fda
life sciences
national blog main
clinical trials
boston blog main
indiana blog main
indiana top stories
national top stories
boston top stories
amgen
new york blog main
san francisco blog main
san francisco top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
abbvie
allergan
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
genentech
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
calcitonin gene-related peptide
chronic migraine
drugs
europe top stories
What
fda
12
×
drug
approval
new
won
medicines
migraine
class
eli
approved
lilly
treatment
bio
blueprint
cancer
companies
decades
designed
developed
drugs
known
lilly’s
medicine
news
nod
pain
regulatory
ret
roundup
starts
wins
acute
address
addresses
adults
alkermes
allergan
amgen
announced
antibody
Language
unset
Current search:
fda
×
" eli lilly "
×
@bgr.com
3 years ago
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines